Supply shortage limits COVID-19 antibody treatment in ND
BISMARCK – Increased demand and limited supply have led to a change in how COVID-19 monoclonal antibody treatments will be distributed across the nation, impacting the availability of treatment for those infected with COVID-19, according to the North Dakota Department of Health.
“While there is a shortage of supply, those who need the treatment are encouraged to ask their health care provider,” said Tim Wiedrich, the department’s Health Resources and Response section chief. “The N.D. Department of Health will be working to distribute North Dakota’s allocation to facilities across the state.”
“Those who have been hesitant about receiving COVID-19 vaccine may be counting on monoclonal antibodies for treatment if they become sick,” said ND State Health Officer Nizar Wehbi. “Due to increased national demand and very limited supply, Monoclonal antibody treatments may not be as available. Vaccination is still the best protection against severe illness, hospitalization, and death from COVID-19. North Dakotans who have not yet been vaccinated are encouraged to do so.”